Search research articles
Contact Us
Filters
Showing results (131-140 of 138) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 138 results.
The New England Journal of Medicine
|
March 29, 2018
The Verge of Collapse
Matthew Weinstock, Anand Vaidya, Souheil El-Chemaly, et al.
Diabetes
|
December 29, 2005
Evaluation of beta-cell replication in mice transgenic for hepatocyte growth factor and placental lactogen: comprehensive characterization of the G1/S regulatory proteins reveals unique involvement of p21cip
Irene Cozar-Castellano, Matthew Weinstock, Marcia Haught, et al.
British Journal of Haematology
|
June 3, 2015
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations
Cindy Varga, Wanling Xie, Jacob Laubach, et al.
British Journal of Haematology
|
March 5, 2019
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine
Myrna R Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, et al.
The Lancet. Oncology
|
September 17, 2021
Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study
Matthew S Davids, Benjamin L Lampson, Svitlana Tyekucheva, et al.
Haematologica
|
February 4, 2021
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model
Dina Stroopinsky, Jessica Liegel, Manoj Bhasin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2025
Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease
Matthew S Davids, Christine E Ryan, Benjamin L Lampson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2024
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease
Matthew S Davids, Christine E Ryan, Benjamin L Lampson, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 138) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 138 results.
The New England Journal of Medicine
|
March 29, 2018
The Verge of Collapse
Matthew Weinstock, Anand Vaidya, Souheil El-Chemaly, et al.
Diabetes
|
December 29, 2005
Evaluation of beta-cell replication in mice transgenic for hepatocyte growth factor and placental lactogen: comprehensive characterization of the G1/S regulatory proteins reveals unique involvement of p21cip
Irene Cozar-Castellano, Matthew Weinstock, Marcia Haught, et al.
British Journal of Haematology
|
June 3, 2015
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations
Cindy Varga, Wanling Xie, Jacob Laubach, et al.
British Journal of Haematology
|
March 5, 2019
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine
Myrna R Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, et al.
The Lancet. Oncology
|
September 17, 2021
Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study
Matthew S Davids, Benjamin L Lampson, Svitlana Tyekucheva, et al.
Haematologica
|
February 4, 2021
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model
Dina Stroopinsky, Jessica Liegel, Manoj Bhasin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2025
Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease
Matthew S Davids, Christine E Ryan, Benjamin L Lampson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2024
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease
Matthew S Davids, Christine E Ryan, Benjamin L Lampson, et al.
Page
of 14